DK1389116T3 - Kathartisk præparat - Google Patents

Kathartisk præparat

Info

Publication number
DK1389116T3
DK1389116T3 DK02771715T DK02771715T DK1389116T3 DK 1389116 T3 DK1389116 T3 DK 1389116T3 DK 02771715 T DK02771715 T DK 02771715T DK 02771715 T DK02771715 T DK 02771715T DK 1389116 T3 DK1389116 T3 DK 1389116T3
Authority
DK
Denmark
Prior art keywords
cathartic preparation
cathartic
preparation
Prior art date
Application number
DK02771715T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of DK1389116T3 publication Critical patent/DK1389116T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02771715T 2001-05-18 2002-05-17 Kathartisk præparat DK1389116T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29163501P 2001-05-18 2001-05-18
PCT/JP2002/004768 WO2002094274A1 (en) 2001-05-18 2002-05-17 Cathartic composition

Publications (1)

Publication Number Publication Date
DK1389116T3 true DK1389116T3 (da) 2008-06-23

Family

ID=23121127

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02771715T DK1389116T3 (da) 2001-05-18 2002-05-17 Kathartisk præparat

Country Status (18)

Country Link
US (2) US6956056B2 (es)
EP (1) EP1389116B1 (es)
JP (1) JP4597481B2 (es)
KR (1) KR100867295B1 (es)
CN (1) CN1273140C (es)
AR (3) AR035242A1 (es)
AT (1) ATE387204T1 (es)
AU (1) AU2002307725B2 (es)
BR (1) BR0209863A (es)
CA (1) CA2445651C (es)
DE (1) DE60225266T2 (es)
DK (1) DK1389116T3 (es)
ES (1) ES2301681T3 (es)
MX (1) MXPA03010510A (es)
NZ (1) NZ529406A (es)
PT (1) PT1389116E (es)
TW (2) TWI324589B (es)
WO (1) WO2002094274A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
PT1562604E (pt) * 2002-10-23 2012-04-09 Sucampo Ag Compostos de prostaglandina para o tratamento de obesidade
EP1575596B1 (en) * 2002-12-27 2016-06-22 Sucampo AG Derivatives of prostaglandins for treating irritable bowel syndrome and/or functional dyspepsia
US7049319B2 (en) 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
TWI387454B (zh) 2004-09-02 2013-03-01 Sucampo Ag 治療胃腸道疾病之方法及組成物
US20070071793A1 (en) * 2005-09-23 2007-03-29 Leon Clark Cure for prostate enlargement frequency of urination and cancer
CA2819844C (en) * 2006-02-07 2015-09-15 R-Tech Ueno, Ltd. Prostaglandin derivatives
CN102050808B (zh) * 2009-11-02 2014-03-12 上海天伟生物制药有限公司 一种前列腺素中间体的制备方法
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
US11534404B2 (en) 2016-10-06 2022-12-27 Sucampo Ag Multilayer beads for pharmaceutical use
US10457623B1 (en) * 2018-07-13 2019-10-29 Chirogate International Inc. Process for the preparation of Lubiprostone and intermediates thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1396207A (en) * 1972-04-27 1975-06-04 Upjohn Co Prostaglandin intermediates and the preparation thereof
US3969376A (en) * 1973-07-20 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin E1 analogs
ZA744581B (en) * 1973-07-20 1975-07-30 Upjohn Co Prostoglandin analogs
US3969381A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin B1 analogs
US3969379A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin A1 analogs
GB8305697D0 (en) * 1983-03-02 1983-04-07 Erba Farmitalia Pharmaceutical compositions
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
JPH0681728B2 (ja) * 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
GB2210556B (en) * 1987-10-02 1991-07-17 Ueno Seiyaku Oyo Kenkyujo Kk The use of 15-keto-16-halo-prostaglandins in cathartic compositions
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
DK0857718T3 (da) * 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
JP4786866B2 (ja) * 2001-08-31 2011-10-05 スキャンポ・アーゲー クロライドチャンネルオープナーとしてのプロスタグランジンアナログ

Also Published As

Publication number Publication date
DE60225266T2 (de) 2009-03-19
CN1273140C (zh) 2006-09-06
AU2002307725B2 (en) 2008-07-10
MXPA03010510A (es) 2004-03-02
CA2445651C (en) 2011-08-09
AR110149A2 (es) 2019-02-27
ES2301681T3 (es) 2008-07-01
US6956056B2 (en) 2005-10-18
US20050261375A1 (en) 2005-11-24
JP4597481B2 (ja) 2010-12-15
TWI324589B (en) 2010-05-11
AR098744A2 (es) 2016-06-08
KR20040020055A (ko) 2004-03-06
EP1389116B1 (en) 2008-02-27
NZ529406A (en) 2005-09-30
DE60225266D1 (de) 2008-04-10
CN1509176A (zh) 2004-06-30
BR0209863A (pt) 2004-06-08
JP2004529960A (ja) 2004-09-30
TW200944210A (en) 2009-11-01
KR100867295B1 (ko) 2008-11-06
US20030022933A1 (en) 2003-01-30
PT1389116E (pt) 2008-04-11
ATE387204T1 (de) 2008-03-15
WO2002094274A1 (en) 2002-11-28
US7459583B2 (en) 2008-12-02
AR035242A1 (es) 2004-05-05
CA2445651A1 (en) 2002-11-28
TWI320711B (en) 2010-02-21
EP1389116A1 (en) 2004-02-18

Similar Documents

Publication Publication Date Title
DK1857105T3 (da) Kathartisk præparat
DE50204184D1 (de) Espressobrüheinrichtung
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
CY2014009I2 (el) Παρασιτοκτονα σκευασματα
DE50204386D1 (de) Kreuztransducer
DE50103741D1 (de) Welle-Nabe-Verbindung
ATE335486T1 (de) Hydrazono-malonitrile
DK1389116T3 (da) Kathartisk præparat
DE50203984D1 (de) Kugelgelenk
DE50203412D1 (de) Schwenkkolbenverdränger
ATE355059T1 (de) Isoxazolopyridinone
DE50201862D1 (de) Messwandler
DE50203093D1 (de) Losradlager
ATA18372001A (de) Gelenksbolzenbaueinheit
DE50202088D1 (de) Garmodulsystem
DE10295006D2 (de) Bauwerksabdichtung
DE50108381D1 (de) Synchronisierschaltungsanordnung
AT500276B1 (de) Radschwenksystem
DE10196706D2 (de) Nagelfeile
DE10142202B8 (de) Hochvakuumbedampfungsanlage
DE10295832D2 (de) Dioxathianone
ATA6162001A (de) Schneekette
BRMU8103332U2 (pt) terço fácil
SE0101122D0 (sv) Novel use